Chemed Price to Book Ratio 2010-2025 | CHE

Historical price to book ratio values for Chemed (CHE) over the last 10 years. The current price to book ratio for Chemed as of July 18, 2025 is 5.59.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chemed Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2025-07-18 451.30 5.57
2025-03-31 614.78 $81.09 7.58
2024-12-31 528.85 $76.87 6.88
2024-09-30 599.36 $82.78 7.24
2024-06-30 540.66 $80.51 6.72
2024-03-31 639.18 $78.46 8.15
2023-12-31 581.86 $73.69 7.90
2023-09-30 516.77 $67.91 7.61
2023-06-30 538.20 $63.42 8.49
2023-03-31 533.93 $58.84 9.07
2022-12-31 506.42 $53.70 9.43
2022-09-30 432.80 $48.73 8.88
2022-06-30 464.98 $46.16 10.07
2022-03-31 501.42 $44.74 11.21
2021-12-31 523.28 $41.79 12.52
2021-09-30 459.72 $50.87 9.04
2021-06-30 468.62 $55.59 8.43
2021-03-31 453.81 $58.51 7.76
2020-12-31 525.25 $56.65 9.27
2020-09-30 473.38 $50.48 9.38
2020-06-30 444.23 $47.39 9.37
2020-03-31 426.34 $43.28 9.85
2019-12-31 431.99 $45.58 9.48
2019-09-30 410.34 $42.21 9.72
2019-06-30 354.33 $39.05 9.07
2019-03-31 314.01 $37.08 8.47
2018-12-31 277.66 $37.25 7.45
2018-09-30 312.95 $35.67 8.77
2018-06-30 314.84 $34.76 9.06
2018-03-31 266.72 $31.98 8.34
2017-12-31 237.29 $33.69 7.04
2017-09-30 197.05 $30.08 6.55
2017-06-30 199.18 $28.48 6.99
2017-03-31 177.68 $31.30 5.68
2016-12-31 155.78 $32.38 4.81
2016-09-30 136.74 $30.22 4.53
2016-06-30 131.89 $28.69 4.60
2016-03-31 130.81 $29.46 4.44
2015-12-31 144.39 $30.55 4.73
2015-09-30 128.45 $29.12 4.41
2015-06-30 125.97 $28.41 4.43
2015-03-31 114.52 $28.07 4.08
2014-12-31 101.16 $26.72 3.79
2014-09-30 98.31 $25.57 3.84
2014-06-30 89.35 $25.86 3.46
2014-03-31 85.08 $25.57 3.33
2013-12-31 72.71 $25.53 2.85
2013-09-30 67.67 $24.34 2.78
2013-06-30 68.36 $25.93 2.64
2013-03-31 75.29 $25.73 2.93
2012-12-31 64.41 $24.46 2.63
2012-09-30 64.88 $24.73 2.62
2012-06-30 56.43 $23.55 2.40
2012-03-31 58.36 $22.71 2.57
2011-12-31 47.56 $21.71 2.19
2011-09-30 50.90 $21.55 2.36
2011-06-30 60.51 $22.97 2.63
2011-03-31 61.38 $21.91 2.80
2010-12-31 58.40 $21.71 2.69
2010-09-30 52.26 $23.51 2.22
2010-06-30 49.99 $22.61 2.21
2010-03-31 49.65 $21.91 2.27
2009-12-31 43.70 $21.10 2.07
2009-09-30 39.88 $20.26 1.97
2009-06-30 35.77 $19.42 1.84
2009-03-31 35.20 $18.56 1.90
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.602B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.633B 18.36
Encompass Health (EHC) United States $11.089B 23.51
DaVita (DVA) United States $10.658B 14.98
Elanco Animal Health (ELAN) United States $7.340B 15.72
Option Care Health (OPCH) United States $4.827B 21.52
RadNet (RDNT) United States $4.313B 273.76
Amedisys (AMED) United States $3.199B 21.51
Addus HomeCare (ADUS) United States $1.969B 21.62
LifeStance Health (LFST) United States $1.641B 0.00
Astrana Health (ASTH) United States $1.270B 31.46
U.S Physical Therapy (USPH) United States $1.124B 29.02
Pennant (PNTG) United States $0.808B 29.66
Aveanna Healthcare Holdings (AVAH) United States $0.773B 44.00
Atai Life Sciences (ATAI) Germany $0.647B 0.00
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00